Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.55B |
| 2 |
Gilead Sciences
GILD
|
+$968M |
| 3 |
CME Group
CME
|
+$953M |
| 4 |
Broadcom
AVGO
|
+$809M |
| 5 |
TE Connectivity
TEL
|
+$753M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$2.6B |
| 2 |
CSX Corp
CSX
|
+$2.44B |
| 3 |
Amgen
AMGN
|
+$2.27B |
| 4 |
AbbVie
ABBV
|
+$1.67B |
| 5 |
Netflix
NFLX
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.59% |
| 2 | Technology | 15.06% |
| 3 | Communication Services | 14.47% |
| 4 | Consumer Discretionary | 13.12% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Aramark
ARMK
$15.9B
| $581M | 0.17% |
18,690,464
-6,239,597
| -25% | -$182M |
|
127
Procter & Gamble
PG
$338B
| $559M | 0.16% |
6,720,251
-6,946,721
| -51% | -$568M |
|
128
Molina Healthcare
MOH
$10.9B
| $553M | 0.16% |
3,716,228
-115,614
| -3% | -$14.8M |
|
129
Williams-Sonoma
WSM
$29B
| $551M | 0.16% |
16,765,730
+704,590
| +4% | +$22.3M |
|
130
Kimberly-Clark
KMB
$36.7B
| $546M | 0.16% |
4,801,319
-3,438,217
| -42% | -$386M |
|
131
Bank of Montreal
BMO
$129B
| $538M | 0.16% |
6,518,386
-296,228
| -4% | -$23.8M |
|
132
Sempra
SRE
$56.5B
| $530M | 0.15% |
9,322,744
-5,323,612
| -36% | -$308M |
|
133
Petrobras Class A
PBR.A
$102B
| $523M | 0.15% |
50,036,725
-15,507,843
| -24% | -$151M |
|
|
ATVI
134
DELISTED
Activision Blizzard
ATVI
| $520M | 0.15% |
6,251,684
+5,737,000
| +1,115% | +$435M |
|
135
Televisa
TV
$1.52B
| $517M | 0.15% |
29,146,000
| – | – |
|
136
Vertex Pharmaceuticals
VRTX
$133B
| $512M | 0.15% |
+2,655,018
| New | +$473M |
|
137
Kraft Heinz
KHC
$29.7B
| $511M | 0.15% |
9,265,149
+57
| +0% | +$3.41K |
|
138
Alcoa
AA
$13.4B
| $503M | 0.15% |
12,455,973
-2,812,437
| -18% | -$122M |
|
139
Toronto Dominion Bank
TD
$205B
| $500M | 0.15% |
8,228,296
+6,489
| +0.1% | +$386K |
|
140
GE Aerospace
GE
$375B
| $492M | 0.14% |
9,095,899
-17,192,940
| -65% | -$1.06B |
|
141
Middleby
MIDD
$5.38B
| $481M | 0.14% |
3,719,552
+235,328
| +7% | +$26.9M |
|
142
General Motors
GM
$76B
| $481M | 0.14% |
+14,279,230
| New | +$526M |
|
143
Workday
WDAY
$43.9B
| $460M | 0.13% |
3,150,040
+2,857,657
| +977% | +$397M |
|
144
Salesforce
CRM
$160B
| $458M | 0.13% |
2,882,002
-267
| -0% | -$39.6K |
|
145
Enbridge
ENB
$112B
| $457M | 0.13% |
14,153,123
-6,405,383
| -31% | -$224M |
|
146
Ultragenyx Pharmaceutical
RARE
$2.62B
| $447M | 0.13% |
5,856,138
+100,575
| +2% | +$8.18M |
|
147
Insulet
PODD
$10B
| $444M | 0.13% |
4,188,814
-413,919
| -9% | -$38.8M |
|
148
Willis Towers Watson
WTW
$31.8B
| $441M | 0.13% |
3,131,340
-2,181,979
| -41% | -$330M |
|
149
Johnson Controls International
JCI
$91.4B
| $441M | 0.13% |
+12,586,298
| New | +$464M |
|
|
PRAH
150
DELISTED
PRA Health Sciences, Inc.
PRAH
| $436M | 0.13% |
3,954,022
+97
| +0% | +$10.1K |
|
Similar funds
Capital Research Global Investors's Q3 2018 Portfolio in Review
As of Q3 2018, Capital Research Global Investors held 485 positions worth $344B, down 6% from $366B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Capital Research Global Investors withdrew a net $39.8B in Q3 2018, closing 49 positions and reducing 220 holdings. Its most notable exit was Praxair Inc, an estimated $1.17B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Capital Research Global Investors opened a new position in TE Connectivity worth $720M.
- Capital Research Global Investors's largest Q3 2018 buy was TE Connectivity: 8,189,669 shares worth $720M.
- Capital Research Global Investors added most to Meta Platforms (Facebook) in Q3 2018, an estimated $4.55B increase.
- Capital Research Global Investors's biggest Q3 2018 reduction was Wells Fargo, cutting an estimated $2.6B.
- Capital Research Global Investors fully exited Praxair Inc in Q3 2018, selling an estimated $1.17B.
- Capital Research Global Investors's ten largest holdings make up 29% of its $344B portfolio in Q3 2018.
- Capital Research Global Investors opened 45 new positions and closed 49 in Q3 2018.
- Capital Research Global Investors's portfolio value fell 6% quarter-over-quarter to $344B.
Based on Capital Research Global Investors's 13F filing for Q3 2018, filed 14 Nov 2018.